We are a vertically integrated pharmaceutical company committed to delivering high-quality healthcare for patients around the world.
Accelerating access to quality medicines
We work to identify new and existing gaps, and strengthen healthcare and life science by addressing them.
Addressing unmet and evolving patient needs
We are enhancing our capacities to develop high-quality, differentiated solutions to ensure good health and well-being for people everywhere.
Creating benchmarks in innovation
We believe that our strengths lie in leveraging them appropriately to deliver long-term, sustainable value to our customers and shareholders.
Delivering sustained returns
Working with an unflinching sense of duty towards the communities where our operations thrive and the planet at large.
Touching lives in myriad ways
Seeking innovative minds who aspire to broaden the horizons of quality healthcare and connecting them with growth opportunities are our top priorities as responsible employers.
Developing path-breaking solutions
Our latest press releases and announcements.
Updated MRPs after GST rate reduction
Setting the trend
About Us
At Alembic, our mission is to bring you access, information and innovations in healthcare.
Capabilities
A laser-sharp focus and world-class processes enable us to remain ahead of the compliance curve.
Research and Development
We take a closer look at things, ask questions and bring life-changing healthcare solutions.
Manufacturing Facilities
Therapies
DMF Filings
ANDAs Filings
Employees
Business
Alembic is a multi-product, multi-location enterprise working with some of the biggest pharmaceutical companies in the world to deliver a variety of complex chemistries.
Journey
Started manufacturing tinctures and alcohol at Vadodara
Began production of cough syrups, vitamins, tonics and sulphur drugs
Inaugurated Penicilin plant with Lal Bahadur Shastri in attendance
Initiated bulk manufacturing of Vitamin B12
Manufactured Erythromycin for the first time in Indian history
Launched Althrocin, a brand of Erythromycin
Althrocin moves to become top selling brand in India
Kickstarted the production of synthetic, organic API
Received ISO 14000 certification for facilities at Vadodara
Began production of Cephalosporin C
Acquired non-oncology business of M/s Dabur Pharma Ltd.
Addressed chronic therapies through multiple marketing divisions
Demerged from Alembic group to form Alembic Pharmaceutical Ltd, and gets listed
Unveiled the Dematology division in domestic market with 8 products
Started first NDA with a partner and commenced filing in EU, Australia and Brazil
Launched Aripiprazole and established the US Front-end as also transitioning to in-house marketing in the US
Struck a JV with Orbicular – Aleor Dermaceutical Limited to develop dermatology products for the international market
2017
Inaugurated the manufacturing facility for Oncology medicines, including oral solids and liquid injectable vials, in the presence of the Hon’ble Chief Minister of Gujarat, Shri. Vijay Rupani
Acquired Orit Laboratories LLC, USA
Received FDA approvals for Aleor’s dermatology facility
Granted approvals for Oncology oral solid facility
Entered a JV to foray into the China market
Achieved the milestone of US$ 250 million sales in the US frontend
Responsibility
We are dedicated to creating more sustainable solutions and resilient communities.
Investors
Stock Price
Careers
A team of passionate individuals help us find answers to complex healthcare problems
Media